Cite Filings / XTLB
Feed Companies Filings Check
Sign in

CIK 0001023549

  • Non-accelerated filer

XTL BIOPHARMACEUTICALS LTD

Sign in to watch
Ticker
XTLB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Incorporated
Israel
Entity type
Other
Phone
+972 99557080
Business address
XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
Filings Financials Insiders Search text
All 546 Insider Trading 49 Beneficial Ownership Interest 13 Public Offerings 28 Foreign Private Issuers 415 Others 41
›
Filed in
  1. No filings match these filters. Clear filters
  2. 4 Open-market buy ● 10% owner bought 1,300,000 shares at $2.89 ($3,757,000) 2008-01-04
  3. 4 Open-market buy ● 10% owner bought 1,950,000 shares at an average $2.72 ($5,299,585) 2008-01-02
  4. 4 Open-market buy ● 10% owner bought 300,000 shares at $2.60 ($778,620) 2007-12-31
  5. 3/A Insider 3/A 2007-12-31
  6. 3 Insider Initial Statement of Ownership 2007-12-07
  7. 3 Insider Initial Statement of Ownership 2007-08-22
  8. 4 Open-market buy CEO bought 15,279 shares at $1.30 ($19,863) 2007-08-21
  9. 4 Open-market buy CEO bought 1,600 shares at $2.98 ($4,768) 2006-08-28
  10. 3 Insider Initial Statement of Ownership 2006-08-17

Page 3 of 3 · 49 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…